Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO and G-CSF in Brain Injury
NCT02018406Phase 2Recruiting
- Sponsor
- Yonsei University
- Start
- Jul 2011
- Primary completion
- Dec 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin, granulocyte colony-stimulating factor in stroke, cerebral palsy (CP), Atypical Parkinsonian disorders (APD), sponsored by Yonsei University. Started Jul 2011; status: recruiting.
02
Drugs
erythropoietingranulocyte colony-stimulating factor
03
Conditions
strokecerebral palsy (CP)Atypical Parkinsonian disorders (APD)
Beyond the preview
Go deeper on NCT02018406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018406.